Paradigm Financial Partners, LLC Moderna, Inc. Transaction History

Paradigm Financial Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 12, 2023	SELL	$96.41 - $126.61 $1,638 - $2,152	-17 Reduced 0.53%	3,171 $327,000
Q2 2023 Jul 13, 2023	BUY	$118.5 - $160.53 $21,211 - $28,734	179 Added 5.95%	3,188 $387,000
Q1 2023 Apr 11, 2023	BUY	$135.66 - $197.02 $52,229 - $75,852	385 Added 14.67%	3,009 $462,000
Q4 2022 Jan 27, 2023	BUY	$118.38 - $210.04 $10,180 - $18,063	86 Added 3.39%	2,624 $0
Q3 2022 Nov 09, 2022	BUY	$118.07 - $194.18 $299,661 - $492,828	2,538 New	2,538 $318,000

1,113

241M

9.26M

12.1M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $25.7B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Paradigm Financial Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Paradigm Financial Partners, LLC with notifications on news.